Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer
MOULDER, Stacy L, FRASER SYMMANS, W, ZWIEBEL, James, VALERO, Vicente, HORTOBAGYI, Gabriel N, ESTEVA, Francisco J, BOOSER, Daniel J, MADDEN, Timothy L, LIPSANEN, Cindy, LINDA YUAN, BREWSTER, Abenaa M, CRISTOFANILLI, Massimo, HUNT, Kelly K, BUCHHOLZ, Thomas A
Published in Clinical cancer research (01.12.2008)
Published in Clinical cancer research (01.12.2008)
Get full text
Journal Article